AMTI AMTI

Applied Molecular Transp... Stock Price

2.09
0.16 (8.29%)
Upgrade to Real-Time
Afterhours (Closed)
2.09
Volume 215,175
Bid Price 1.70
Ask Price 2.09
News -
Day High 2.07

Low
1.74

52 Week Range

High
33.28

Day Low 1.8306
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Applied Molecular Transport Inc AMTI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.16 8.29% 2.09 20:00:00
Open Price Low Price High Price Close Price Prev Close
1.91 1.8306 2.07 1.99 1.93
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,173 215,175 $ 2.01 $ 431,809 - 1.74 - 33.28
Last Trade Time Type Quantity Stock Price Currency
19:59:17 2 $ 1.97 USD

Period:

Draw Mode:

Applied Molecular Transport Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 80.79M 38.65M 13.01M $ - $ - -2.67 -0.60
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 383.19k 2.70%

more financials information »

Applied Molecular Transp... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AMTI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.882.071.741.88297,9500.2111.17%
1 Month2.252.731.742.11350,953-0.16-7.11%
3 Months4.054.341.742.80450,648-1.96-48.4%
6 Months8.248.761.744.43403,403-6.15-74.64%
1 Year27.6533.281.7410.00322,339-25.56-92.44%
3 Years18.0678.221.7422.51274,943-15.97-88.43%
5 Years18.0678.221.7422.51274,943-15.97-88.43%

Applied Molecular Transp... Description

Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.


Your Recent History
NASDAQ
AMTI
Applied Mo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now